Tuesday, June 6, 2017
- 1:45pm-3:15pm
-
Intracortical plasticity is preserved in de novo Parkinson’s disease: a tSMS study.
Parkinson's Disease: Pathophysiology · Exhibit Hall C
- 1:45pm-3:15pm
-
Intrajejunal levodopa infusion (ILI) for Parkinson’s Disease (PD): A Canadian Experience
Therapy in Movement Disorders · Exhibit Hall C
- 1:45pm-3:15pm
-
Intranasal delivery of insulin for the restoration of memory signaling in Alzheimer disease
Therapy in Movement Disorders · Exhibit Hall C
- 1:45pm-3:15pm
-
Is the GBA2 a new modifier for Gauchers’s disease and GBA1-related Parkinson’s disease?
Parkinson's Disease: Pathophysiology · Exhibit Hall C
- 1:45pm-3:15pm
-
Istradefylline improves motor symptoms in Parkinson’s disease: A meta-analysis
Therapy in Movement Disorders · Exhibit Hall C
- 1:45pm-3:15pm
-
Juvenile Huntington Disease (JHD) subjects’ stratification according to the mutation-length
Huntington's Disease · Exhibit Hall C
- 1:45pm-3:15pm
-
Large CAG expansions in Huntington disease children: the RAREST-JHD initiative
Huntington's Disease · Exhibit Hall C
- 1:45pm-3:15pm
-
Laryngeal Tardive Dyskinesia in a Patient treated with Haldol
Drug-Induced Movement Disorders · Exhibit Hall C
- 1:45pm-3:15pm
-
Listen to your heart: ordinal pattern statistics reveal altered cardiac rhythm dynamics in LRRK2-nonmanifesting carriers
Parkinson's Disease: Pathophysiology · Exhibit Hall C
- 1:45pm-3:15pm
-
Long-Term Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia: Results From an Open-Label, Long-Term Study
Drug-Induced Movement Disorders · Exhibit Hall C
- «Previous Page
- 1
- …
- 20
- 21
- 22
- 23
- 24
- …
- 38
- Next Page»